期刊
RESPIRATORY RESEARCH
卷 23, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12931-022-02110-w
关键词
Lung adenocarcinoma; Cancer prognosis; DNA damage repair; Cell cycle checkpoint; Gene signature
资金
- Scientific Research Project of Wenzhou Medical University for Talent [QTJ20010]
- National Natural Science Foundation of China [11635013]
In this study, a prognostic model based on 4 DDR-related genes with cell cycle checkpoint function was constructed to predict the survival rate, immune activity, and chemoradiotherapy responsiveness of LUAD patients.
Background: As a DNA surveillance mechanism, cell cycle checkpoint has recently been discovered to be closely associated with lung adenocarcinoma (LUAD) prognosis. It is also an essential link in the process of DNA damage repair (DDR) that confers resistance to radiotherapy. Whether genes that have both functions play a more crucial role in LUAD prognosis remains unclear. Methods: In this study, DDR-related genes with cell cycle checkpoint function (DCGs) were selected to investigate their effects on the prognosis of LUAD. The TCGA-LUAD cohort and two GEO external validation cohorts (GSE31210 and GSE42171) were performed to construct a prognosis model based on the least absolute shrinkage and selection operator (LASSO) regression. Patients were divided into high-risk and low-risk groups based on the model. Subsequently, the multivariate COX regression was used to construct a prognostic nomogram. The ssGSEA, CIBERSORT algorithm, TIMER tool, CMap database, and IC50 of chemotherapeutic agents were used to analyze immune activity and responsiveness to chemoradiotherapy. Results: 4 DCGs were selected as prognostic signatures, and patients in the high-risk group had a lower overall survival (OS).The lower infiltration levels of immune cells and the higher expression levels of immune checkpoints appeared in the high-risk group. The damage repair pathways were upregulated, and chemotherapeutic agent sensitivity was poor in the high-risk group. Conclusions: The 4-DCGs signature prognosis model we constructed could predict the survival rate, immune activity, and chemoradiotherapy responsiveness of LUAD patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据